Check out a summary of the #SingleDrugAssessments in #LungCancer assessed in the last 12 years. Want a more detailed analysis? Request a free trial! https://lnkd.in/dAUP6PVc #marketaccess
IQVIA’s Post
More Relevant Posts
-
// Patient associations/Industry: the key to a positive interaction // What rare disease patients and families want is a simpler life. Discover what makes the relationship between members of a patients’ association and a biotech company work so well in this interview! #kayentis #eCOA #clinicaltrials #raredisease #patientassociation
To view or add a comment, sign in
-
In the fast-paced world of biopharma, finding the right patients is crucial—especially when it comes to rare diseases. Traditional claims data analysis has its limitations, but Ambit's Dynamic LeadGen is here to change the game. Dynamic LeadGen is designed to explicitly address rare disease patient finding challenges, setting a new standard in the market, combining transparency, measurable impact, continuous optimization, proactive adaptation, and a client-centric philosophy. Discover how we're reimagining rare disease patient finding and paving the way for a healthier, more equitable future—read our new blog post now: https://hubs.li/Q02xNn1q0 #dynamicleadgen #patientfinding #patientidentification #claimsdata #claimsdatanalysis #ontheblog #blog
To view or add a comment, sign in
-
Physician-Scientist @ UPenn | National Bestselling Author, Chasing My Cure | Co-Founder @ Every Cure & CDCN
Horizontal thinking saved my life… I didn't have $1 billion or ten years to develop a new drug from scratch. My survival hinged on one critical strategy: identifying and repurposing an existing drug made for another disease to treat my own. This approach isn't just a personal story; it's a powerful example of 'horizontal thinking'—a concept many of us apply without even realizing it. Horizontal thinking is about looking across the spectrum of problems and solutions, rather than tunneling vertically into a single area. It's about exploring what already exists in parallel fields or industries to solve the problems we face. Drug repurposing is a perfect example of this and is why we are so passionate about our mission at Every Cure. How has thinking 'horizontally' helped you solve problems in unexpected ways?
Have you ever used horizontal thinking? Let us know in the comments below. When Every Cure co-founder David Fajgenbaum, MD, MBA, MSc was diagnosed with a rare disease with no known treatments, he knew one thing for certain: “I didn't have a billion dollars and ten years to develop a new drug from scratch.” Fajgenbaum realized he’d need to employ horizontal thinking, which involves taking a solution from one problem and applying it to another. “Repurposing drugs, which is what I did to save my life, and we've done now repeatedly for many other patients, is the ultimate horizontal thinking problem.” Horizontal thinking doesn’t just apply to medicine says Fajgenbaum. Next time you’re facing a problem ask yourself, “Is there a similar challenge that I could learn from that could help me solve the problem I’m facing?” Watch the full episode of #Catalyst here: https://lnkd.in/e-6iKmgH
The power of horizontal thinking | Catalyst w/ Dr. David Fajgenbaum
To view or add a comment, sign in
-
MD #PrecisionMedicine 精密医学 thought & technology leader, Keynote Speaker, industry advisor 30K+ Followers #Biotech #Diagnostics #DrugDiscovery #Innovation #StartUps #ArticialIntelligence #Investing
#PrecisionMedicine & Entrepreneurship: Imagine you have a vision, and some makes it work! @Cytoreason they create the foundations for Precision Medicine and eventually Precision Health, the shift from sickcare to #healthcare https://buff.ly/3QQ4dY5 #PrecisionMedicine #Taxonomy #SystemsMedicine #SystemsBiology #ArtificialIntelligence #Multiomics #DataSciences #Omics #Multiomics #Diagnostics #Pharma #Biotech #DrugDoscovery #DrugDevelopment #Prevention @cytoreason
To view or add a comment, sign in
-
FOR MORE NEWS CLICK 👇 https://bit.ly/45i4HeN [ atOptions = { 'key' : 'e1ee94b4f23ed20d151b11e287321b21', 'format' : 'iframe', 'height' : 250, 'width' : 300, 'params' : {} }; document.write(''); ] Why is it so hard to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a variety of reasons, but a scoping review by Grand et al. (2024) (https://bit.ly/3XfBEqu) provides a nice summary of these issues. Key challenges include small sample sizes for nearly all parameters and lack of data overall. More #FFXIVSweepstakes #givenchyxfreen #vivoY1005GxBecky #jjk255
To view or add a comment, sign in
-
-
$ANVS $9.45 +0.07 (low volume. DAC (dollar average cost) $9.45 (12.11.23). ADD Legacy Holding (LH) status to EXIT at $18.00 (possible upgrade as to price). KEY ELEMENT: AD phase II/III study (Alzheimer’s Disease trial) of its lead compound buntanetap has exceeded full enrollment. Study is a trial investigating the efficacy, safety, and tolerability of buntanetap in patients with mild to moderate AD. note: Expects the data from this study to read out by the end of March 2024. ... from G101SPM - stocktwits.
To view or add a comment, sign in
-
Have you ever used horizontal thinking? Let us know in the comments below. When Every Cure co-founder David Fajgenbaum, MD, MBA, MSc was diagnosed with a rare disease with no known treatments, he knew one thing for certain: “I didn't have a billion dollars and ten years to develop a new drug from scratch.” Fajgenbaum realized he’d need to employ horizontal thinking, which involves taking a solution from one problem and applying it to another. “Repurposing drugs, which is what I did to save my life, and we've done now repeatedly for many other patients, is the ultimate horizontal thinking problem.” Horizontal thinking doesn’t just apply to medicine says Fajgenbaum. Next time you’re facing a problem ask yourself, “Is there a similar challenge that I could learn from that could help me solve the problem I’m facing?” Watch the full episode of #Catalyst here: https://lnkd.in/e-6iKmgH
The power of horizontal thinking | Catalyst w/ Dr. David Fajgenbaum
To view or add a comment, sign in
-
NEW VIDEO 📽️ Advancing therapies for rare conditions is central to Veristat’s mission. Tune into our experts, Cindy Henderson, John Balser, and Barbara Balser as they discuss how we, at Veristat support and work on rare and ultra-rare disease trials. We integrate strategic planning, regulatory, and clinical trial execution to more rapidly advance your complex or novel therapies 👇 https://bit.ly/3POPrio #raredisease #ultrararedisease #VeristatYouTube
Our Focus on Complex and Rare Diseases
To view or add a comment, sign in
-
Designing a #RareDisease #ClinicalTrial first requires a deep understanding of the unique challenges in this space—like a limited understanding of the disease and that few diagnostic tools are available. In this video, learn about the new approaches we continue to pioneer to accelerate the discovery and development of transformative medicines.
To view or add a comment, sign in
-
Only 2 days left! Submit your groundbreaking research, whether it's a Late-Breaking Abstract (LBA) or a regular abstract, for the IASLC #NACLC23 by 10/8/23. Be a catalyst for advancements in #lungcancer treatment. Learn more & submit your abstract: https://ow.ly/c51c50PQMP5 #LCSM
To view or add a comment, sign in
-